As of 2026-02-14, the Intrinsic Value of Neurones SA (NRO.PA) is 42.56 EUR. This NRO.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 36.40 EUR, the upside of Neurones SA is 16.90%.
The range of the Intrinsic Value is 29.92 - 76.68 EUR
Based on its market price of 36.40 EUR and our intrinsic valuation, Neurones SA (NRO.PA) is undervalued by 16.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 29.92 - 76.68 | 42.56 | 16.9% |
| DCF (Growth 10y) | 36.87 - 89.82 | 51.30 | 40.9% |
| DCF (EBITDA 5y) | 33.23 - 41.76 | 37.52 | 3.1% |
| DCF (EBITDA 10y) | 39.63 - 52.58 | 45.84 | 25.9% |
| Fair Value | 24.05 - 24.05 | 24.05 | -33.93% |
| P/E | 36.04 - 51.38 | 42.21 | 16.0% |
| EV/EBITDA | 29.68 - 42.93 | 36.40 | -0.0% |
| EPV | 111.86 - 151.95 | 131.90 | 262.4% |
| DDM - Stable | 20.49 - 70.07 | 45.28 | 24.4% |
| DDM - Multi | 37.03 - 93.14 | 52.39 | 43.9% |
| Market Cap (mil) | 885.61 |
| Beta | 0.37 |
| Outstanding shares (mil) | 24.33 |
| Enterprise Value (mil) | 897.55 |
| Market risk premium | 5.82% |
| Cost of Equity | 7.90% |
| Cost of Debt | 5.00% |
| WACC | 7.71% |